Significantly more TAA-specific CD8+ T cells from HCC patients (expressing the respective TAA) displayed an antigen-experienced phenotype (% antigen-experienced MAGE-A-specific CD8+ T cells in HCC: Median: 52.9%; IQR: 60.8%) [102]. This evidence concerns the gene CD8A and hepatocellular carcinoma.